Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new casodex clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on casodex
- Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
Status: Recruiting, Condition Summary: Prostate Cancer - Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer
Status: Not yet recruiting, Condition Summary: Prostate Cancer - Bicalutamide and Deforolimus in Men With Prostate Cancer
Status: Recruiting, Condition Summary: Prostate Cancer - External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
Status: Recruiting, Condition Summary: Prostate Cancer - Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
Status: Recruiting, Condition Summary: Prostate Cancer - Bicalutamide in Treating Patients With Metastatic Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Pazopanib With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Status: Recruiting, Condition Summary: Prostate Cancer - Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Status: Active, not recruiting, Condition Summary: Cancer-Related Problem/Condition; Prostate Cancer - Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
Status: Recruiting, Condition Summary: Prostate Cancer - Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.
Status: Not yet recruiting, Condition Summary: Prostate Cancer - Adjuvant Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0M0 Prostate Cancer
Status: Recruiting, Condition Summary: Prostate Cancer - CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer
Status: Recruiting, Condition Summary: Prostate Cancer - Casodex vs Placebo in Non-Metastatic Early Prostate Cancer
Status: Active, not recruiting, Condition Summary: Non-Metastatic Prostate Cancer - Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostatic Neoplasms - Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy
Status: Completed, Condition Summary: Prostate Cancer - Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
Status: Active, not recruiting, Condition Summary: Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer - Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer
Status: Completed, Condition Summary: Prostate Cancer - Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy
Status: Active, not recruiting, Condition Summary: Prostate Cancer - Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
Status: Active, not recruiting, Condition Summary: Non-Metastatic Prostate Cancer - Casodex - Nolvadex Combination
Status: Completed, Condition Summary: Gynaecomastia; Prostate Cancer - Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer
Status: No longer available, Condition Summary: Adenocarcinoma of the Prostate - Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer
Status: Recruiting, Condition Summary: Prostate Cancer - Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Status: Recruiting, Condition Summary: Cancer; Prostate Neoplasms - Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Status: Active, not recruiting, Condition Summary: Puberty, Precocious